Ilyang Pharm Financials
| 007570 Stock | 11,300 80.00 0.71% |
Ilyang |
Understanding current and past Ilyang Pharm Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ilyang Pharm's financial statements are interrelated, with each one affecting the others. For example, an increase in Ilyang Pharm's assets may result in an increase in income on the income statement.
Please note, the presentation of Ilyang Pharm's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ilyang Pharm's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ilyang Pharm's management manipulating its earnings.
| Instrument | Korea Stock View All |
| Exchange | Korea Stock Exchange |
| ISIN | KR7007570005 |
| Business Address | 110, Hagal-ro, Yongin, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.ilyang.co.kr |
| Phone | 82 3 1281 7851 |
You should never invest in Ilyang Pharm without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Ilyang Stock, because this is throwing your money away. Analyzing the key information contained in Ilyang Pharm's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Ilyang Pharm Key Financial Ratios
Ilyang Pharm's financial ratios allow both analysts and investors to convert raw data from Ilyang Pharm's financial statements into concise, actionable information that can be used to evaluate the performance of Ilyang Pharm over time and compare it to other companies across industries.| Return On Equity | 0.12 | |||
| Return On Asset | 0.0597 | |||
| Target Price | 44000.0 | |||
| Number Of Employees | 675 | |||
| Beta | -0.0491 |
Ilyang Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ilyang Pharm's current stock value. Our valuation model uses many indicators to compare Ilyang Pharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ilyang Pharm competition to find correlations between indicators driving Ilyang Pharm's intrinsic value. More Info.Ilyang Pharm is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.48 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ilyang Pharm is roughly 2.08 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Ilyang Pharm by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ilyang Pharm's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Ilyang Pharm Systematic Risk
Ilyang Pharm's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ilyang Pharm volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Ilyang Pharm correlated with the market. If Beta is less than 0 Ilyang Pharm generally moves in the opposite direction as compared to the market. If Ilyang Pharm Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ilyang Pharm is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ilyang Pharm is generally in the same direction as the market. If Beta > 1 Ilyang Pharm moves generally in the same direction as, but more than the movement of the benchmark.
Ilyang Pharm November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ilyang Pharm help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ilyang Pharm. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ilyang Pharm based on widely used predictive technical indicators. In general, we focus on analyzing Ilyang Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ilyang Pharm's daily price indicators and compare them against related drivers.
| Information Ratio | (0.37) | |||
| Maximum Drawdown | 7.49 | |||
| Value At Risk | (2.96) | |||
| Potential Upside | 2.0 |
Complementary Tools for Ilyang Stock analysis
When running Ilyang Pharm's price analysis, check to measure Ilyang Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ilyang Pharm is operating at the current time. Most of Ilyang Pharm's value examination focuses on studying past and present price action to predict the probability of Ilyang Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ilyang Pharm's price. Additionally, you may evaluate how the addition of Ilyang Pharm to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |